Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AliquantumRx Logo
AliquantumRx Growth Score
86
CB Rank
1058825
Heat Score
40
AliquantumRx develops Cethromycin-HCl for treating dormant liver-stage malaria and advances biotechnology research.
Founded
obfuscation
Private Baltimore, Maryland, United States1-10 aliquantumrx.com
Biopharma
Biotechnology
Clinical Trials
Overview

AliquantumRx
Growth Score
86
Heat Score
40

Growth Score86
-2 pts
in past quarter
Heat Score 40
14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About AliquantumRx

CB Rank
1058825
AliquantumRx develops Cethromycin-HCl for treating dormant liver-stage malaria and advances biotechnology research.
Founded
obfuscation
Private Baltimore, Maryland, United States1-10 aliquantumrx.com
Biopharma
Biotechnology
Clinical Trials

Details

Legal Name AliquantumRx, Inc.
Also Known As AQR
Operating Status Active
Company Type For Profit
Phone Number +1 202 640 9576
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Cethromycin-HCl
A macrolide antibiotic salt formulation developed for treating dormant liver-stage malaria and other infectious diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Apr 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$66.4KThis year, AliquantumRx is projected to spend $66.4K on IT, according to Aberdeen.

Active Website Tech Count

25AliquantumRx is actively using 25 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.

Total IP

2The intellectual property of AliquantumRx includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is AliquantumRx's headquarters? AliquantumRx is located in Baltimore, Maryland, United States.Who are AliquantumRx's competitors? Alternatives and possible competitors to AliquantumRx may include Bill & Melinda Gates Foundation, Novartis, and  Sanofi.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|